Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05180955
Other study ID # Chest Tube Removal 001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 16, 2022
Est. completion date May 29, 2024

Study information

Verified date June 2024
Source Isala
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study will be conducted as a, prospective, open label, non-inferiority, randomized controlled trial. In the intervention group; chest tube removal will be determined by air flow criteria as indicated by the digital drainage system data. In the control group removal will be determined by the same criteria of the digital drainage system but before removal, a chest tube clamping test will be performed. Primary outcome measure: recurrent pneumothorax after chest tube removal requiring chest tube reinsertion


Description:

Determining and timing of chest tube removal has been a continuous topic of debate amongst both surgeons and pulmonologist. It is plausible that provocative clamping tests are no longer necessary when a digital continuous recording drainage device is used that demonstrates the absence of (intermittent) air leak. However, clamping trials are still performed in clinical care, it is an expert opinion's policy prompted by fear of recurrent pneumothorax and no comparative studies exist. We hypothesize that chest tube removal exclusively based on digital drainage system data is as safe as adding a clamping test before removal in patients treated for pneumothorax or after lung surgery. The study will be conducted as a, prospective, open label, non-inferiority, randomized controlled trial. In the intervention group; chest tube removal will be determined by air flow criteria as indicated by the digital drainage system data. In the control group removal will be determined by the same criteria of the digital drainage system but before removal, a chest tube clamping test will be performed.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date May 29, 2024
Est. primary completion date May 29, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Digital chest tube drainage system - Pneumothorax (primary, secondary, pulmonary surgery) Exclusion Criteria: - Pleural effusion as primary indication for chest tube placement. - Empyema - Suspected chest tube malfunction (e.g., leaking, occlusion, malposition) - Intubated during chest tube removal

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Digital drainage system
In the intervention group; chest tube removal will be determined by air flow criteria as indicated by the digital drainage system data, the tube will not be clamped.
Digital drainage system + clamping trial
In the control group removal will be determined by the same criteria of the digital drainage system but before removal, a chest tube clamping test will be performed.

Locations

Country Name City State
Netherlands Isala Klinieken Zwolle Overijssel

Sponsors (1)

Lead Sponsor Collaborator
Isala

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recurrent pneumothorax after chest tube removal number of patients requiring chest tube reinsertion within 24 hours after chest tube removal for recurrent pneumothorax 0-24 hours after drain removal
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05077111 - A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia Phase 4
Recruiting NCT05230420 - Urine Bag Usage Versus Chest Drain Clamping After Lung Resection Surgeries N/A
Completed NCT04848727 - Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants